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Periodontal diseases usually refer to common inflammatory disorders known as gingivitis and periodontitis, which are caused by a pathogenic microbiota in the subgingival 
biofilm, including Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, 
Tannerella forsythia and Treponema denticola that trigger innate, inflammatory, and 
adaptive immune responses. These processes result in the destruction of the tissues 
surrounding and supporting the teeth, and eventually in tissue, bone and finally, tooth loss. 
The innate immune response constitutes a homeostatic system, which is the first line of 
defense, and is able to recognize invading microorganisms as non-self, triggering immune 
responses to eliminate them. In addition to the innate immunity, adaptive immunity cells 
and characteristic cytokines have been described as important players in the periodontal 
disease pathogenesis scenario, with a special attention to CD4+ T-cells (T-helper cells). 
Interestingly, the T cell-mediated adaptive immunity development is highly dependent on 
innate immunity-associated antigen presenting cells, which after antigen capture undergo 
into a maturation process and migrate towards the lymph nodes, where they produce distinct 
patterns of cytokines that will contribute to the subsequent polarization and activation of 
specific T CD4+ lymphocytes. Skeletal homeostasis depends on a dynamic balance between 
the activities of the bone-forming osteoblasts (OBLs) and bone-resorbing osteoclasts (OCLs). 
This balance is tightly controlled by various regulatory systems, such as the endocrine 
system, and is influenced by the immune system, an osteoimmunological regulation 
depending on lymphocyte- and macrophage-derived cytokines. All these cytokines and 
inflammatory mediators are capable of acting alone or in concert, to stimulate periodontal 
breakdown and collagen destruction via tissue-derived matrix metalloproteinases, a 
characterization of the progression of periodontitis as a stage that presents a significantly 
host immune and inflammatory response to the microbial challenge that determine of 
susceptibility to develop the destructive/progressive periodontitis under the influence of 
multiple behavioral, environmental and genetic factors.
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I- ETIOLOGY OF PERIODONTAL 
DISEASE
Periodontal diseases usually refer to common 
inflammatory disorders known as gingivitis and 
periodontitis, which are caused by a pathogenic 
microbiota in the subgingival biofilm. The bacterial 
challenge induces the production of cytokines 
and chemokines by the gingival epithelium, 
resulting in the expression of adhesion molecules, 
increased permeability of gingival capillaries and 
chemotaxis of polimorphonuclear neutrophils 
through the junctional epithelium and into the 
gingival sulcus53,173. If this process continues, the 
inflammation extends deep into the tissues and 
causes loss of supporting connective tissue, alveolar 
bone and also allows the formation of a periodontal 
pocket. Those recently described pathologic events 
constitute and characterize what we know as 
periodontitis84.
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A hallmark of periodontitis is that is caused by 
complex subgingival microbial communities, which 
can comprise around 500 bacterial species171. 
The human body contains various and distinctive 
ecosystems providing a unique environment for 
colonizing microorganisms. Moreover, the oral 
cavity presents numerous surfaces for microbial 
colonization. For instance, the periodontal sulcus/
pocket is partially sheltered from the physical 
shear forces in the oral cavity and contains hard 
and non-shedding surfaces of the tooth root, along 
with the shedding surfaces of gingival mucosa in 
permanent contact with the gingival crevicular 
fluid211. The epithelial surfaces are continuously 
replaced; however, several of the most pathogenic 
bacterial species are able to invade the gingival 
cells and tissues, remaining viable and evading 
the action of different immune cells237. Therefore, 
the subgingival environment has distinct ecological 
determinants, and it can be considered as one of 
the most interesting oral niches for characterizing 
the intimate interplay between oral microbial 
communities and the immune host response.
Usually, a few bacterial species in the subgingival 
biofilm have been associated with diseased 
periodontal tissues and identified as putative 
pathogens. It was concluded that there is strong 
evidence that Porphyromonas gingivalis (P. 
gingivalis), Aggregatibacter  actinomycetemcomitans 
(A. actinomycetemcomitans) and Tannerella 
forsythia (T. forsythia) are periodontal pathogens 
when their presence is in sufficient numbers and 
in susceptible hosts31.
Although many efforts have been made to 
characterize the prevalence of the periodontal 
pathogens described above, there is little consensus 
due to the varied methodologies used. For that 
reason, our group investigated the differences in 
9 bacterial species of the subgingival microbiota 
of chronic periodontitis populations in Chile, 
Spain and Colombia using the same clinical and 
microbiological methods90. In that study, the red 
complex species P. gingivalis and T. forsythia, were 
detected in high frequencies in most of the patients 
and the actives sites. P. gingivalis were the most 
frequently detected in Chilean patients (83.8%) 
and the less frequent in Colombians (65.9%), 
while the frequency of T. forsythia was lower in 
Chile (16.2%) than in Colombia (39%) and Spain 
(36.1%)90. Additionally, our group reported that 
active sites in Chileans with chronic periodontitis 
showed higher mean percentages for P. gingivalis 
of the total anaerobic than inactive sites, and no 
significant differences were found for T. forsythia204. 
Our findings are in agreement with the ones 
previously described by López, et al.137 (2004), 
who found a higher prevalence of P. gingivalis in 
Chilean than US subjects, using checkerboard DNA-
DNA hybridization. This study demonstrated that 
more than 90% of active sites are colonized by red 
complex bacteria, but the prevalence of T. forsythia 
was lower than P. gingivalis and similar in Chilean 
and in US subjects137 (Figure 1).
The high prevalence of P. gingivalis and T. 
forsythia in Chileans with chronic periodontitis was 
in accordance with studies performed in other Latin 
American populations. Using DNA-based methods, it 
was reported a high frequency of P. gingivalis and T. 
forsythia in Brazilian (68% and 45%, respectively) 
and Mexican population (100% and 97.4%, 
respectively)33, 252 (Figure 1). In addition, using 
microbiological cultures, Botero, et al.21 (2007) 
were able to detect P. gingivalis and T. forsythia in a 
high frequency in Colombians patients with chronic 
periodontitis (75.4% and 50%, respectively). 
Together these results indicate that P. gingivalis 
and T. forsythia are frequently detected in Latin 
American population with chronic periodontitis, 
however, the prevalence of P. gingivalis is higher in 
Chile compared to other Latin American countries 
(Figure 1).
Regarding A. actinomycetemcomitans prevalence 
in chronic periodontitis, our group reported that this 
pathogen was detected in a lower proportion than 
P. gingivalis and T. forsythia in Chilean population, 
using microbiological culture54 and DNA probes137. 
Also using microbiological cultures, lower proportions 
and frequency of A. actinomycetemcomitans were 
found in Chilean (19.4%), Colombian (17.1%) 
and Spaniard (16.7%) populations. However, the 
Chilean population presented a higher frequency of 
detection than US patients137 (Figure 1). In contrast, 
in Brazilian35 and Mexican256 patients with chronic 
periodontitis, a higher frequency of detection of A. 
actinomycetemcomitans has been reported, using 
PCR and checkerboard DNA-DNA hybridization, 
respectively. These findings are worth noting, 
since it has been demonstrated that the frequency 
detection of some periodontopathic microorganisms 
in chronic periodontitis subjects was significantly 
higher when detected by PCR than in microbiological 
cultures21.
On the other hand, a very high prevalence 
of P. gingivalis was also found in patients with 
aggressive periodontitis in Chileans55,135,136, 
Brazilians35, Mexicans256 and Colombians subjects21. 
Interestingly, concerning the microbiological profiles 
described in periodontitis, some studies have found 
differences in the periodontal microbiota between 
chronic and aggressive periodontitis21,35,55,256, 
however, more recent studies have reported only 
minor differences in the microbiological profiles of 
both clinical entities186.
Using different DNA-based assays and 
microbiological cultures of periodontal pathogens, 
it has been reported that some populations with 
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aggressive periodontitis have a higher prevalence 
of P. gingivalis compared with the ones with chronic 
periodontitis (Figure 1). For example, our group 
reported that Chilean patients with aggressive 
periodontitis have 86.6%-100% of P. gingivalis 
frequency of isolation, compared with 76.4% in 
chronic periodontitis55. Also using microbiological 
cultures, it was reported a frequency of 92.8% in 
Colombian subjects with aggressive periodontitis 
compared with 75.4% for the ones with chronic 
Author Number of 
individuals
and country
Disease type
(Sample 
description)
Method of
analysis
Prevalence of periodontopathic bacteria per individual
López, 
et al.135 
(1995)
n=15,
Chileans
Localized Juvenile 
Periodontitis (LJP; 
n=10), Generalized 
Juvenile Periodontitis 
(GJP; n=5)
Microbiological 
Culture
(7 bacterial 
species)
P. gingivalis
A. actinomycetemcomitans
LJP
70.0%
40.0%
GJP
80.0%
60.0%
López, 
et al.136 
(1996)
n=24,
Chileans
Localized Juvenile 
Periodontitis (LJP; 
n=18), Generalized 
Juvenile Periodontitis 
(GJP; n=6)
DNA probes
(3 bacterial 
species)
P. gingivalis
A. actinomycetemcomitans
LJP
94.4%
38.9%
GJP
0%
0%
Tinoco, 
et al.235 
(1997)
n=25,
Brazilians
Localized Aggressive 
periodontitis (LAgP)
Microbiological 
Culture
(1 bacterial 
species)
A. actinomycetemcomitans LAgP
76%
López134 
(2000)
n=60,
Chileans
Progressive 
Periodontitis (PP)
DNA probe
(3 bacterial 
species)
P. gingivalis
A. actinomycetemcomitans
PP
96%
11.6%
López, 
et al.137 
(2004)
n=26,
Chileans
Chronic Periodontitis 
(CP)
Checkerboard 
DNA-DNA 
hybridization
(40 bacterial 
species)
P. gingivalis
T. forsythia
A. actinomycetemcomitans
CP
>9x105 
counts
>6x105 
counts
>3x105 
counts
Gajardo, 
et al.55 
(2005)
n=53,
Chileans
Chronic 
Periodontitis (CP; 
n=17), Localized 
(LAgP; n=30) 
and Generalized 
Aggressive 
Periodontitis (GAgP; 
n=6)
Microbiological 
Culture
(8 bacterial 
species)
P. gingivalis
A. actinomycetemcomitans
CP
76.4%
35.2%
LAgP
86.6%
16.6%
GAgP
100%
33.3%
Cortelli, 
et al.35 
(2005)
n=203,
Brazilians
Aggressive 
Periodontitis (AgP; 
n=25)
Chronic Periodontitis 
(CP; n=178)
PCR
(5 bacterial 
species)
P. gingivalis
T. forsythia
A. actinomycetemcomitans
CP
68.0%
45.5%
41.6%
AgP
80.0%
56.0%
72.0%
Ximenez-
Fyvie, 
et al.256 
(2006)
n=77,
Mexicans
Generalized 
Aggressive 
Periodontitis (GAgP; 
n=19)
Chronic
Periodontitis (CP; 
n=39)
Periodontally Healthy 
(H; n=19)
Checkerboard 
DNA-DNA 
hybridization
(40 bacterial 
species)
P. gingivalis
T. forsythia
A. actinomycetemcomitans
CP
100%
97.4%
89.7%
GAgP
100%
94.4%
94.7%
H
89.5%
89.5%
73.7%
Botero, 
et al.21 
(2007)
n=110,
Colombians
Chronic Periodontitis 
(CP; n=68), 
Aggressive 
Periodontitis 
(AgP; n=12) and 
Periodontally Healthy 
(H; n=30)
Microbiological 
culture, 
biochemical 
tests and PCR
(11 bacterial 
species)
P. gingivalis
T. forsythia
A. actinomycetemcomitans
CP
75.4%
50.0%
15.4%
AgP
92.8 %
51.4 %
10.0%
H
10.0 %
6.7 %
6.7 %
Herrera, 
et al.90 
(2008)
n=114,
Colombians 
(co), Chileans 
(ch), Spaniards 
(sp)
Chronic Periodontitis
(Chileans; n=37, 
Colombians; n=41, 
Spaniards; n=36)
Microbiological 
culture
(9 bacterial 
species)
P.gingivalis
T. forsythia
A. actinomycetemcomitans
CP (ch)
83.4%
16.2%
19.4%
CP (co)
65.9%
39.0%
17.1%
CP (sp)
77.8%
36.1%
16.7%
Rescala, 
et al.186 
(2010)
n=44,
Brazilians
Generalized Chronic 
periodontitis (GCP; 
n=20), Generalized 
Aggressive 
periodontitis (GAgP; 
n=14), Gingivitis (G; 
n=10)
Checkerboard 
DNA-DNA 
hybridization 
(40 bacterial 
species)
P. gingivalis
T. forsythia
A. actinomycetemcomitans
GCP
>6x105 
counts
>6x105 
counts
<2x105 
counts
GAgP
>6x105 
counts
>6x105 
counts
<2x105 
counts
G
<2x105 
counts
<1x105 
counts
<2x105 
counts
Figure 1- Comparison of the frequency of detection of Porphyromonas gingivalis, Tannerella forsythia and Aggregatibacter 
actinomycetemcomitans in Latin American subjects with different periodontal diagnosis
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periodontitis21. According to these results, using 
PCR, it has been reported that Brazilian patients 
with aggressive periodontitis had 80% of prevalence 
compared with 68% for chronic periodontitis 
patients, whereas similar prevalence was observed 
for T. forsythia in both pathologies35. In contrast, 
studies performed with checkerboard DNA-DNA 
hybridization method showed a similar amount of 
P. gingivalis and T. forsythia in Mexicans subjects256 
as well as in Brazilians186 (Figure 1).
After red complex bacteria, the prevalence of 
A. actinomycetemcomitans is the most elevated 
in Chilean134,136 and Brazilian235 populations with 
aggressive periodontitis; however, it is quite 
different among populations. For example, Chilean 
subjects had a lower frequency of detection of 
this microorganism in aggressive (16.6% in 
localized aggressive periodontitis and 33.3% in 
generalized aggressive periodontitis) than in chronic 
periodontitis (35.2%)54. In addition, Botero, et 
al.21 (2007) found in Colombian patients a 10% of 
frequency of detection in aggressive and 15.4% in 
chronic periodontitis. In contrast, Ximenez-Fyvie, et 
al.256 (2006) describes in Mexican subjects a higher 
prevalence of A. actinomycetemcomitans (94.7%) 
in generalized aggressive periodontitis patients.
Regarding the studies described above, some 
of them have shown differences on the microbial 
profiles in subjects with the same clinical entities, 
when comparing populations of different countries. 
Therefore, the only presence of particular bacteria 
could not explain by itself the etiology of periodontal 
diseases. Consequently, many of the current 
studies are focusing their analysis on the bacterial 
subspecies of the main periodontopathogens (P. 
gingivalis, A. actinomycetemcomitans and T. 
forsythia), their serotypes and strains with specific 
genetic characteristics151.
P. gingivalis, a Gram-negative, black pigmented, 
assacharolytic and strict anaerobic bacteria, 
has long been considered an important member 
of the periodontopathic microbiota involved in 
periodontal disease progression and bone and 
tissue destruction93. A large body of evidence 
supports that P. gingivalis produces an array of 
potential virulence factors164. Some of them are 
lipopolysaccharide, capsule, hemagglutinins, 
fimbriae, serB protein and cysteine proteases called 
“gingipains”82,93,100,176,177,261. The pathological actions 
of gingipains includes aminoacid uptake from 
host proteins, fimbrial maturation, macrophage 
CD14 degradation and cleavage of complement 
component C5131. Altogether, these effects facilitate 
a sustained colonization of P. gingivalis.
On the other hand, similar to other Gram-
negative bacteria, this microorganism can 
synthesize an extracellular capsule, composed of 
negatively charged polysaccharides that enable 
this bacterium to withstand phagocytosis50,198. Six 
different serotypes based on capsular (K) antigens 
have been described for P. gingivalis and designated 
K1- K6125,243. Recently, Vernal, et al.249 (2009) has 
demonstrated that each P. gingivalis K serotype 
induces a different type of immune response, 
suggesting a role of the capsule in the activation 
of dendritic cells. This virulence factor may be an 
important pathogenic determinant in the initiation, 
progression, and/or severity of the periodontitis.
In addition, another critical virulence factor is 
major fimbriae. These are filamentous components 
on the cell surface, and their subunit protein, 
fimbrillin (FimA), reportedly acts on bacterial 
interaction with host tissues by mediating bacterial 
adhesion and colonization in targeted sites4. P. 
gingivalis strains had been classified into six 
different variants (types I–V and type Ib) based on 
their different nucleotide sequences. Several studies 
have been performed to investigate the prevalence 
and distribution of these fimA genotypes in subjects 
with different periodontal conditions in different 
geographical locations147-149,157. From those results, 
it can be inferred that the type II fimA genotypes 
is the most prevalent in periodontitis patients, 
while the second most prevalent has been variably 
found to be type IV, type Ib, or type I, depending 
on the ethnic population studied. Conversely, type 
I and type III fimA are more prevalent in non-
periodontitis subjects5.
Furthermore, lipopolysaccharide represents a 
major component of P. gingivalis outer membrane 
and in contrast to most Gram-negative bacteria, 
lipid A from P. gingivalis lipopolysaccharide 
present heterogeneous molecules that induce a 
weak agonistic and antagonistic innate immune 
response42,104. These mechanisms are proposed to 
be essential in disrupting the oral homeostasis and 
oral health.
Regarding A. actinomycetemcomitans, is a 
Gram-negative bacterium that produces numerous 
factors that have been well-characterized, including 
adherence proteins, biofilm polysaccharides, 
lipopolysaccharide, and toxins51. Specifically, 2 
protein toxins have been related to periodontal 
diseases mediated by A. actinomycetemcomitans: 
the cytolethal distending toxin (CDT)202 and 
leukotoxin (LtxA)116,126, which have been implicated 
in impaired of human lymphocyte function 
by perturbing cell cycle progression and the 
lymphocytic and monomyelocytic lineages lysis207, 
respectively. Both proteins are delivered to the 
host cell by outer membrane vesicles (OMVs)190 
and participate in immune evasion mechanisms107.
Finally, T. forsythia is a Gram-negative bacterium 
strongly associated with the development and/
or progression of periodontal disease. Only a 
few virulence factors of T. forsythia have been 
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recognized to be involved in the pathogenesis of 
periodontitis, which includes sialidase (SiaHI) and 
NanH, a cysteine protease with hemolysin activity 
(PrtH), a trypsin-like protease and an extracellular 
protein, BspA, mediating the attachment to 
fibronectin and fibrinogen, an apoptosis-inducing 
activity, alpha-D-glucosidase and N-acetyl-beta-
glucosaminidase, a hemagglutinin, components 
of the bacterial S-layer, and methylglyoxal 
production81,122,200.
Taken together, these antecedents are showing 
that several virulence factors produced by these 
periodontal pathogens might be important in the 
immune response impairment, and permit to these 
bacteria to exert a significant impact on the oral 
homeostasis and the development of periodontal 
diseases.
I I -  I N N A T E  I M M U N I T Y  I N 
PERIODONTAL DISEASES
Periodontal disease is initiated by small subset 
of endogenous gram-negative periodontal bacteria, 
including Porphyromonas gingivalis, Aggregatibacter 
actinomycetemcomitans, Tannerella forsythia 
and Treponema denticola, which trigger innate, 
inflammatory, and adaptive immune responses. 
These processes result in the destruction of the 
tissues surrounding and supporting the teeth, and 
eventually result in tissue, bone, and, finally, tooth 
loss5,113,130.
The innate immune response constitutes a 
homeostatic system, which is the first line of defense 
and is able to recognize invading microorganisms as 
non-self, triggering immune responses to eliminate 
them. The effectors mechanisms of innate immune 
are improved by adaptive immune involving 
an efficient loop for microbial clearance, where 
triggering of proper innate mechanisms ensures 
an effective adaptive immune response, which 
potentiate these innate effectors functions against 
periodontopathic bacteria. The primary response to 
pathogens in the innate immune system is triggered 
by Pattern Recognition Receptors (PRRs) that bind 
Pathogen-Associated Molecular Patterns (PAMPs), 
found in a broad type of organisms. These receptor 
types include toll-like receptors, nucleotide-binding 
oligomerization domain (NOD) proteins, cluster of 
differentiation 14 (CD14), complement receptor-3, 
lectins and scavenger receptors3,9.
Latin-American research about innate immune 
response and periodontitis is mainly focused on the 
toll-like receptor and neutrophils. Such research is 
developed in Brazil, Chile and Mexico56,64,131,187,189 
(Figure 2).
Toll-like receptors
Among the most important families of pathogen-
associated molecular patterns are the toll-
like receptors (TLRs), which recognize, with 
selectivity, a large number of varied and complex 
pathogen-associated molecular patterns. Toll-like 
receptors are evolutionarily conserved proteins 
that also have a highly conserved intracellular 
TIR domain involved in protein-protein interaction 
and signaling activation. The extracellular domain, 
with Leucine-rich repeats (LRRs), is related to 
ligand recognition. Leucine-rich repeats motifs 
vary among toll-like receptors, although how 
they can discriminate among different pathogen-
associated molecular patterns still remains 
unclear3. Among the 10 human toll-like receptors 
identified so far, toll-like receptor-2 and toll-like 
receptor-4 are the most defined members. Toll-like 
receptor-2 is mostly involved in the recognition of 
a variety of different bacterial cell components, 
such as peptidoglycan and lipoproteins. Toll-like 
receptor-4 has been shown to specifically recognize 
lipopolysaccharide of Gram-negative bacteria 
and acts in cooperation with several protein 
components, such as lipopolysaccharide-binding 
protein and CD143,9,112,152. Research has established 
that toll-like receptors are expressed in periodontal 
tissues152,222. Since the gingiva is constantly exposed 
to microbes present in plaque biofilm, toll-like 
receptors signaling plays an important role in 
the innate immune response and maintenance 
of periodontal health. However, over-production 
of pro-inflammatory cytokines due to chronic 
stimulation of toll-like receptors, they may lead to 
tissue destruction13,254.
Several studies have been made in Latin America 
about toll-like receptors and periodontitis64,131,189 
and all of them, like in almost all dental scientific 
literature, are related to toll-like receptors 2, toll-
like receptors 4 (expressed at the cell surface), toll-
like receptors 3 or toll-like receptors 9 (expressed 
at intracellular compartments). Rojo-Botello, et 
al.189 (2012) showed, using confocal microscope, 
that toll-like receptors 2, 3, 4 and 9 are expressed 
in human gingival tissue, and that the expressions 
were higher in all periodontal patient than in healthy 
individuals. The authors also demonstrated that 
the expression of these receptors is positively 
regulated with the severity of periodontal disease. 
These data are confirming and extending previous 
evidence showing the expression of diverse toll-
like receptors in various types of cells in the 
healthy and diseased human gingival tissue, and 
supports the possible involvement of the toll-like 
receptors system in the pathogenesis of periodontal 
disease12,152,222,240. Furthermore, the study of Rojo-
Botello shows, for the first time, that the expression 
of some toll-like receptors (toll-like receptors 2, 4 
and 9) is significantly increased in gingival tissue 
from patients with periodontal disease associated 
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with type 2 diabetes, with regard to tissues from 
subjects without diabetes and with or without 
periodontitis189. These findings are consistent with 
the notion sustaining a correlation between toll-like 
receptors expression with disease severity, or with 
the degree of inflammation.
Using a model of experimental periodontitis, a 
Brazilian group has studied the mechanisms that 
modulate the outcome of A. actinomycetemcomitans-
induced periodontal disease in toll-like receptors 2-/-64 
and toll-like receptors 4-/-131 mice. Toll-like receptors 
2-/- mice developed more severe periodontitis 
after infection, characterized by significantly 
higher bone loss. Also an intraperitoneal A. 
actinomycetemcomitans infection model was used 
to characterize the role of toll-like receptors 2 in the 
recruitment of macrophages and neutrophils. The 
initiation of the inflammatory response in toll-like 
receptors 2-/- mice was reduced compared to wild 
type (WT) controls. Specifically, they observed that 
the influx of neutrophils and macrophages into the 
peritoneal cavities was significantly decreased, and 
the levels of interleukin-1β, tumor necrosis factor-α, 
CXCL2, and CCL5 were significantly lower in toll-
like receptors 2-/- mice64. These data highlight the 
involvement of toll-like receptors 2 in recognizing 
A. actinomycetemcomitans and its essential role 
in controlling A. actinomycetemcomitans infection. 
On the other hand toll-like receptors 4-/- mice 
orally infected with A. actinomycetemcomitans 
developed less severe periodontitis, when compared 
with wild type (WT) control mice, characterized 
by a significantly lower bone loss accompanied 
by a reduced inflammatory cell migration and 
Author (year) Methods Main findings Origin
Gamonal, et al.56 (2003) Evaluation of apoptosis by 
TUNEL technique in ex vivo 
culture of gingival biopses in 
presence of GM-CSF.
GM-CSF diminishes the 
neuthophil apoptosis 
by reduction of Bax 
expression, suggesting a 
novel mechanism by which 
neutrophils accumulate 
in chronic periodontitis 
patients.
Chile-Spain
Restaíno, et al.187 (2007) Neutrophils from 23 chronic 
periodontitis and 30 
healthy subjects stimulated 
with P. gingivalis and A. 
actinomicetemcomitans
Neutrophils from chronic 
periodontitis subjects are 
more reactive, suggested 
by their higher response 
toward periodontal pathogen 
stimulation.
Chile
Gelani, et al.64 (2009) A. actinomicetemcomitans-
induced periodontal disease 
in TLR2-/- mice
TLR2 is involved in A. 
actinomicetemcomitans 
recognition and has an 
essential role in controlling 
A. actinomicetemcomitans 
infection.
Brazil
Lima, et al.131 (2010) A. actinomicetemcomitans-
induced periodontal disease 
in TLR4-/- mice
TLR4 has a role 
in controlling A. 
actinomicetemcomitans 
infection.
Brazil
Rojo-Botello, et al.189 (2012) Expression of TLRs 2, 3, 
4 and 9 in gingival tissues 
from healthy individuals and 
from periodontal patients 
with or without type 2 
diabetes
The expression of TLRs 2, 
3, 4 and 9 in gingival tissue 
is higher in individuals with 
diabetes, and is positively 
regulated with the severity of 
periodontal disease.
Mexico
Figure 2- Evidence regarding innate immune response in periodontitis conducted by Latin-American groups 
GM-CF: Granulocyte monocyte-colony stimulating factor
TRL:Toll-like receptor
TUNEL: TdT-mediated dUTP-biotin nick end labeling
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inflammatory cytokine production (interleukin-
1β and tumor necrosis factor-α) in periodontal 
tissues. Moreover, this absence of toll-like receptors 
4 activation leads to impaired myeloperoxidese 
activity in the periodontum and possibly facilitates 
systemic bacteria dissemination and proliferation135. 
Regarding P. gingivalis, an interaction of fimbriae 
with TLR2 has also been shown to induce cross talk 
of TLR2 with the coreceptors CR5, CXCL4, and CR3, 
resulting in distinct responses82. The plasticity and 
diversity in downstream signaling when TLR2 is 
activated is further underscored by the observation 
that P. gingivalis live cells induce a different pattern 
of TLR2-dependent cytokines than that induced 
by FimA or LPS preparations alone in mouse 
peritoneal macrophages265. It is likely that different 
TLR2-activating ligands vary in their abilities to 
engage TLR2 and specific coreceptors. In terms 
of responses, TLR2 engagement has been shown 
to trigger production of both proinflammatory and 
anti-inflammatory cytokines.
The bacterial composition of plaque remains 
relatively stable despite regular exposure to minor 
environmental perturbations. The changes that 
affect the homeostasis leading to shifts for example 
in the frequent exposure of plaque to low pH; an 
increase flow of gingival crevicular fluid; and as 
microflora shifts from being mainly Gram-positive 
to being comprised of increased levels of obligately 
anaerobic, asaccharolytic Gram-negative organisms 
and the rate of acid production following sugar 
intake could be reduced by fluoride, have been 
incorporated into a new hypothesis: the ecological 
plaque hypothesis, to explain the relationship 
between the plaque microflora and the host in 
health and disease, and to identify new strategies 
for disease prevention145.
The recent advancements in the periodontal 
research field are consistent with a new model of 
pathogenesis, according to which periodontitis is 
initiated by a synergistic and dysbiotic microbial 
community rather than by a select bacterial 
complex, that is, polymicrobial synergy and 
dysbiosis model (PSD model)79,80.
Polymorphonuclear neutrophils
Polymorphonuclear neutrophils are one of the 
first-responders of inflammatory cells to migrate 
toward the site of periodontal inflammation, 
following chemoattractants such as interleukin-8 
secreted by oral epithelial cells, connective fibroblast 
and immune cells. In addition, polymorphonuclear 
neutrophils are recruited to the site of injury within 
minutes following injury, and are the hallmark of 
acute inflammation39.
Though the polymorphonuclear neutrophils 
are essentially protective cells, alterations in 
polymorphonuclear neutrophil function result 
in an acute, severe and generalized clinical 
phenotype of periodontitis in humans42. These 
alterations can involve different functions such as 
adhesion capabilities, chemotaxis response and 
phagocytic function and, by default, the specific 
timing of polymorphonuclear neutrophils-based 
periodontal immune response. Their cytoplasmic 
granules contain several enzymes that, on release, 
degrade the structural elements of tissue cells and 
extracellular matrix. Polymorphonuclear neutrophils 
are short-lived cells, and also upon interaction 
with pathogens and its toxins, they die in great 
numbers at acute inflammatory periodontal sites. 
Therefore, the accumulation and massive death 
of polymorphonuclear neutrophils are among 
major causes for tissue breakdown in progressive 
periodontitis. P. gingivalis associated periodontitis 
has been related to a disruption on E-selectin 
endothelial cells expression and interleukin-8 
expression from gingival epithelial cells that 
could alter significantly the polymorphonuclear 
neutrophils transit to the inflammation site39,42. 
Regarding the response of polymorphonuclear 
neutrophils, our group studied peripheral blood 
neutrophils in periodontitis-affected patients, 
and in healthy controls towards stimulation to 
P. gingivalis and A. actinomycetemcomitans 
extracts187. Neutrophil response, followed by matrix 
metalloproteinase-9 and interleukin-8 secretion, 
was assayed by zymography and enzyme-linked 
immunosorbent assay, respectively, on both whole 
blood and purified neutrophils. In addition to 
periodontal pathogen extracts, known stimulating 
agents were tested, such as Escherichia coli 
lipopolysaccharide, phytohemagglutinin, and 
zymosan A. Polymorphonuclear neutrophil response 
expressed as a secretion ratio, under stimulated and 
non-stimulated conditions in purified neutrophils 
from patients. The tests showed that the matrix 
metalloproteinase-9 exhibited a significantly 
higher secretion ratio with lipopolysaccharide 
and P. gingivalis, whereas interleukin-8 showed a 
larger increase in secretion ratio in the presence 
of P. gingivalis, A. actinomycetemcomitans, 
lipopolysaccharide, and zymosan A. Our study 
concludes that peripheral neutrophils of periodontitis-
affected patients are more reactive than in controls 
as suggested by their significantly higher response 
toward periodontal pathogen extracts and other 
stimulating agents. This hyper-reactivity may be 
secondary to the inflammatory reaction occurring 
in the gingival tissue during periodontal disease187. 
Finally, another study from our group, showed that 
granulocyte monocyte-colony stimulating factor 
(GM-CSF) present in the gingival crevicular fluid, 
could delay polymorphonuclear neutrophil apoptosis 
in chronic periodontitis56. To probe that, we utilized 
cultures of human gingival biopsies obtained 
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from periodontitis subjects. When the sample 
was embedded in complete medium containing 
granulocyte monocyte-colony stimulating factor, 
the total number of TUNEL-positive cells was 
reduced, therefore showing its delaying effect on 
the apoptotic process. The localized accumulation 
of functional polymorphonuclear neutrophils at 
sites of inflammation is pivotal in the host defense 
against infection, and the orderly elimination of 
these cells is equally important in the resolution of 
the inflammatory response56.
III- INVOLVEMENT OF T-CELL 
SUBSETS, CYTOKINES AND ORAL 
VIRUSES IN PERIODONTAL DISEASES 
PATHOGENESIS
In addition to the innate immunity, adaptive 
immunity cells and characteristic cytokines 
have been described as important players in the 
periodontal disease pathogenesis scenario, with a 
special attention to CD4+ T-cells (T-helper cells). 
Interestingly, T cell-mediated adaptive immunity 
development is highly dependent on innate 
immunity-associated antigen presenting cells, which 
after antigen capture undergo into a maturation 
process and migrate towards the lymph nodes, 
where they produce distinct patterns of cytokines 
that will contribute to the subsequent polarization 
and activation of specific T CD4+ lymphocyte38.
CD4+ T-cells were subdivided initially into two 
subsets, designated T-helper 1 and T-helper 2, on 
the basis of their pattern of cytokine production155. 
As a general rule, T-helper 1 cytokines have 
been associated with infectious inflammatory 
bone destruction, while its classic antagonists 
T-helper 2 cytokines are described to minimize 
bone loss30,73,180,184. Nevertheless, the discovery 
of new T-helper subsets with prominent roles in 
the modulation of host responses determined 
the re-examination of T-helper 1/T-helper 2 
dichotomy paradigm in chronic inflammatory 
diseases, including periodontal diseases21,73,103,205,252. 
Th17 cells emerged as a remarkable T subset, 
with inflammatory properties involved in a 
series of infectious, autoimmune and osteolytic 
processes44,106,224,226.
On the other hand, regulatory T cells (Tregs) 
comprise a FOXp3-dependent CD4+CD25+ 
T-helper subpopulation with suppressive effects 
on inflammatory osteolysis, thought to be mediated 
by cytokines such transforming growth factor-b, 
interleukin-10 and the CLTA418,106. Other regulatory 
T cell subsets, namely T-helper 3 and Tr1, are 
characterized by the specific production of 
transforming growth factor-b or interleukin-10, 
respectively16,17,103.
Also, additional T-helper subsets, such as 
T-helper 9 and T-helper 22 cells, are described to play 
important roles in the modulation of inflammatory 
immune responses, interacting with the previously 
mentioned T-helper subpopulations103,154,252.
Therefore, we must consider that there are 
at least four types of T-helper cells, T-helper 
1, T-helper 2, T-helper 17, and T-regulatory 
cells, which collectively play an important role 
in orchestrating adaptive immune responses 
to various infectious agents, and also a great 
influence on the inflammatory and autoimmune 
diseases outcome. Upon TCR-mediated cell 
activation, and under a critical influence of 
cytokines that generate specific patterns of 
signaling and activate definite transcription 
factors, naïve CD4+ T cells can differentiate into 
characteristic polarized subsets. Specific subsets 
of cytokines are involved in differentiation of 
each lineage: interleukin-12/interferon-γ for 
T-helper 1, interleukin-4/interleukin-2/interleukin-7 
for T-helper 2, transforming growth factor-β/
interleukin-6/interleukin-21/interleukin-23 for 
T-helper 17, and transforming growth factor-β/
interleukin-2 for T-regulatory cells. The major effect 
of such polarizing cytokines is the generation of 
specific transcription factors involved in T-helper 
cell differentiation: T-bet controls T-helper 1 fate, 
GATA3 is involved in T-helper 2 generation, RORγt 
for T-helper 17, and Foxp3 for T-regulatory cells.
Once differentiated, the polarized T-helper 
subsets express a signature pattern of chemokine 
receptors expression that determines the selective 
migration of CD4+ T helper subsets to the response 
foci, in which these cells will produce distinct 
and characteristic cytokines20,108,155. Indeed, the 
transcription factors involved in T-helper cell 
differentiation directly bind to the effector cytokine 
genes (Ifng, Il4/Il13, Il17a/Il17f; for T-helper 1, 
T-helper 2 and T-helper 17 cells respectively) at 
promoters and regulatory elements, resulting the 
prototypical production of cytokines that defines 
the T-helper subsets266,267. In this context, we 
describe in the sequence the major T-helper subsets 
and their potential role in the pathogenesis of 
periodontal diseases.
T-helper 1
T-helper 1 cells are primarily involved in the cell-
mediated immunity, and are generated under the 
influence of interleukin-12/interferon-γ signaling 
that leads to the activation of the transcription 
factor T-bet. Interferon-γ, the signature cytokine 
of T-helper 1-type responses, is associated with 
the production of inflammatory cytokines and 
chemokines and with phagocyte activation7,155,194,199. 
A controversial role for interferon-γ in bone lytic 
lesions has been described, since in vitro data 
clearly demonstrated that interferon-γ induces rapid 
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degradation of the RANK adapter protein TRAF6 by 
the ubiquitin-proteasome system, resulting in the 
inhibition of the RANKL-signaling and its subsequent 
osteoclastogenic events227. These results can 
be interpreted in support of the hypothesis that 
T-helper 1 cells are associated with the stable 
lesions while T-helper 2 cells are associated with 
disease progression66. However, Garlet lab group57,58 
demonstrated in vivo that the pro-inflammatory 
effect of interferon-γ mediates the upregulation of 
the levels of tumor necrosis factor-a and interleukin-
1b, which in turn can upregulate RANKL, being the 
in vivo outcome opposite to the in vitro scenario.
Accordingly, as previously demonstrated by 
Gamonal and Garlet groups, interferon-γ is present 
at high levels in human and experimental periodontal 
lesions, being associated with progressive lesions 
or higher severity periodontal diseases forms46,61,94. 
Human and experimental data suggests that 
interferon-γ can contribute to periodontitis 
onset and progression by distinct mechanisms. 
With special interest in T-helper 1 cells, our 
group demonstrates in a series of studies that 
interferon-γ stimulates osteoclast formation and 
bone loss in vivo via antigen-driven T cell activation 
or through the chemoattraction of RANKL+ 
cells58,63,183. In fact, T-helper 1 cells (characterized as 
CD3+CCR5+CXCR3+ cells) are an important source 
of RANKL throughout experimental periodontitis183. 
Complementarily, interferon-γ can contribute to 
the migration of CD4/80+ cells, whose phenotype 
demonstrate monocyte/macrophage-like phenotype 
that can be interpreted as a potential osteoclast 
precursor’s subpopulation. Finally, interferon-γ 
seems to play an active role in the control of 
periodontal infection, possibly mediated by 
macrophages and neutrophils activation146,199 clearly 
evidenced by the severe impairment of protective 
immunity to A. actinomycetemcomitans infection, 
as demonstrated by the higher bacterial load in 
periodontium, increased acute phase response, 
and bacterial dissemination followed by death of 
interferon-γ KO mice56. The immune protection 
mediated by interferon-γ characteristically involves 
leukocyte recruitment and its subsequent activation 
at inflammatory foci199.
T-helper 2
T-helper 2 cells commitment and action 
is primarily dependent of interleukin-4, the 
prototypical T-helper 2 cytokine, and of the 
transcription factor GATA37,152,191. Interleukin-4 
presents marked suppressive and anti-inflammatory 
properties mediated by its capacity to inhibit the 
transcription of pro-inflammatory cytokines and 
interferon-γ, then suppressing the polarization 
of T-helper 1 cells2,7,20,102. Also, in spite of some 
controversies, interleukin-4 can present anabolic 
properties in distinct tissues, characterized by the 
ability to inhibit the production of tissue degrading 
factors such as matrix metalloproteinases (and 
other proteases) and the major osteoclastogenic 
factor RANKL, and concomitantly induce the 
upregulation of its respective inhibitors TIMPs and 
osteoprotegerin98,192,194. Therefore, interleukin-4 
could contribute to the attenuation of both 
soft and mineralized tissue destruction, which 
could reinforce its potential protective nature in 
periodontitis pathogenesis67.
Indeed, the concentration of interleukin-4 
in gingival crevicular fluid was demonstrated to 
decrease from periodontal health to disease, 
suggesting that this cytokine could mediate the 
remission or improvement of periodontal lesions179. 
Experimental data support the protective role of 
T-helper 2 cells, since T-helper 2-biased immune 
response in mice resulted in minimal lesions 
after P. gingivalis challenge220, and the adoptive 
transfer T-helper 2 cells attenuates the severity 
of periodontal diseases47. In this context, it is 
important to remember that interleukin-4 cab 
induces the production of cytokines with similar 
or complementary suppressive properties, such as 
interleukin-10105,172. Interestingly, interleukin-10 
was considered initially one of the T-helper 
2-signature cytokines along interleukin-4, but 
more recent studies have been associating this 
cytokine more closely to T-regulatory cells. It is 
also important to mention that recent studies have 
been identified an interesting plasticity among 
T-helper subsets, which may also account for some 
controversies in previous studies.
However, early studies demonstrated that B cells 
outnumber T cells in periodontal lesions, which in the 
view of the association of T-helper 2 responses with 
B cell function and humoral immunity development, 
results in the hypothesis that a T-helper 2 lesion was 
involved in the progression of chronic periodontitis65. 
Recent evidences, demonstrating that B cells can be 
a RANKL source, and that the majority of B cells in 
periodontal lesions are RANKL+110 are interpreted 
along with the T-helper 2 lesion hypothesis. While in 
this context the T-helper 2-B cell axis is considered 
detrimental, it is important to consider that the 
humoral immunity axis involving T-helper 2 and 
B cells is also thought to contribute to the host 
protection against periodontal pathogens75,168,169,200.
T-helper 17
T-helper 17 cell lineage is characterized as an 
interleukin-17-producing CD4 T cell subset, which 
undergoes its polarization due to a complex cytokine 
signaling that can involve, transforming growth 
factor-β/interleukin-6/interleukin-21/interleukin-23 
and resulting in the activation of the transcription 
factor ROR-g. In this process, transforming growth 
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factor-β and interleukin-6 signaling together 
cooperate to drive T-helper 17 commitment, 
while the cytokine interleukin-23 amplifies and 
stabilizes the T-helper 17 phenotype in chronic 
inflammatory reactions. Interestingly, T-helper 
17 cells develop through cytokine signals distinct 
from, and antagonized by, products of the T-helper 
1 and T-helper 2 lineages7,44,194. Once differentiated, 
RORγ can bind to multiple sites in the Il17a/Il17f 
locus, including the promoters of these cytokines, 
leading to the characteristic interleukin-17 
production, which in turn leads to the induction 
of many proinflammatory factors such as tumor 
necrosis factor, interleukin-6, and interleukin-1β. 
In fact, these innate immunity cytokines have been 
associated with periodontitis, since the upregulation 
of such mediators expression/production by 
interleukin-17 clearly points to a destruction of 
such cytokines in periodontitis context. Accordingly, 
Gamonal groups presented the initial evidences that 
T-helper 17 cytokines are produced in periodontal 
lesions and are supposed to contribute to disease 
progression, which was confirmed latter by Garlet 
group and others12,24,162,163,223,247. Besides the classical 
phagocyte activating cytokines, recent evidences 
demonstrate that the T-helper 17/interleukin-17 
axis, by itself or along with pro-inflammatory and 
T-helper 1 cytokines, mobilizes macrophages and 
neutrophils204,262, which could also contribute to 
exacerbate host responses in periodontal tissues. 
In accordance with this hypothesis, interleukin-17 
was also recently described to increase toll-like 
receptors responsiveness in human gingival 
epithelial cells13, suggesting that this cytokine can 
play an active role in potentiating innate immunity 
mechanisms in periodontal environment. In addition 
to the upregulation of pro-inflammatory cytokines 
production, interleukin-17 was described as an 
inducer of RANKL production120,195,197. However, 
experimental studies in rodents demonstrate that 
the interleukin-17 deficient mice may present 
increased or decreased bone lesions in response 
to periodontal pathogens challenge, being the 
exact role of interleukin-17 in periodontitis still 
unclear166,262.
T-regulatory cells
Regulatory T cells were initially described as 
CD4+CD25+ T cells that specifically regulate the 
activation, proliferation, and effector function of 
activated conventional T cells, determining the 
outcome of several immunological settings ranging 
from infectious diseases to immunopathology 
and autoimmunity7,15,194,203. T-regulatory cells 
characteristically express as phenotypic markers 
the transcription factor forkhead box P3 (FOXp3), 
CD103, the glucocorticoid-inducible tumor necrosis 
factor receptor (GITR), the inhibitory molecule 
cytotoxic T-lymphocyte-nassociated molecule 4 
(CTLA-4) and cell surface transforming growth 
factor-β1, among other surface molecules203. 
However, recent studies demonstrate that 
FOXP3+ T cells are not a uniform population, but 
phenotypically and functionally diverse populations. 
Currently, there are two accepted major types of 
FOXP3+ T-regulatory cells: endogenous or natural 
Treg (nTreg), a stable subset derived from the 
thymus and thought to control autoreactivity, and 
adaptive or induced T-regulatory cells (aTreg or 
iTreg), a less stable subpopulation supposed to 
regulate responses upon antigenic exposure in 
the periphery15,150,191,193. Interestingly, T-regulatory 
cells from noninflamed peripheral tissues are 
considered to be in a resting state with little 
suppressor activity, but under certain inflammatory 
conditions, these cells are stimulated and undergo 
rapid reprogramming to acquire helper/effector 
functions. Foxp3 is the master regulator for both 
iT-regulatory cells and nT-regulatory cells, and its 
stimulation through TCR and transforming growth 
factor-βR signaling is essential to drive iT-regulatory 
cells development. Along with other transcription 
factors, such as Runx, Foxp3 positively regulates 
T-regulatory cells-specific gene expression and 
negatively regulates genes not expressed in 
Tregs15,150,191.
Immunohistological, flow-cytometry and 
molecular analysis of periodontal tissues characterized 
the presence and identity of T-regulatory cells 
by the expression of its phenotypic markers 
FOXp3, CTLA-4, interleukin-10, GITR, CD103 and 
CD45RO25,158. Despite the controversies regarding 
T-regulatory cells subtypes and phenotypes, and 
the lack of definitive markers, according to the 
current knowledge it is possible to suggest that 
iT-regulatory cells would be the cells found in 
periodontal tissues. While the effector mechanisms 
of T-regulatory cells action can greatly vary, 
inhibitory factors such as CTLA-4, interleukin-10 
and transforming growth factor-β are supposed to 
mediate suppressive activity in peripheral tissues. 
Accordingly, these three factors are also supposed 
to attenuate periodontal diseases progression, 
restraining inflammation and osteoclastogenesis 
locally25,60,62,109,127,165,221. Indeed, Gamonal group 
demonstrated that, in active periodontal lesions, 
T-regulatory cells-related cytokines levels are 
negatively correlated with RANKL levels, reinforcing 
its protective role against tissue destruction45,46,221. 
In accordance with such hypothesis, Garlet group 
was the first to establish a cause/effect association 
between T-regulatory cells and periodontitis severity 
by means of T-regulatory cells function ablation, 
in an experimental periodontitis model, where 
the migration of CD4+FOXp3+ cells to periodontal 
tissues after experimental infection is associated 
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with a decline in the disease progression rate, and 
its inhibition resulted in increased alveolar bone loss 
and inflammatory cell migration59. In addition to 
the attenuation of tissue destruction, T-regulatory 
cells-associated cytokines such as interleukin-10 
and transforming growth factor-β are associated 
with tissue repair in different models29.
Additional T-helper subsets
While T-helper 1, T-helper 2, T-helper 17 and 
T-regulatory cells are the most recognized and 
studied T-helper subsets, recent studies suggest the 
existence of other CD4 lymphocytes subtypes with 
distinguished immunoregulatory properties. T-helper 
9 cells characteristically produce interleukin-9, 
initially designated as a T-helper 2 cytokine that 
exerts pro- or anti-inflammatory activities by 
modulating T-regulatory cells and/or T-helper 
17 cells development and function49,128,129,161. 
Additionally, the recently identified T-helper 22 
cells produces interleukin-22, which can exerts 
pro-inflammatory effects by a synergistic action 
with classic pro-inflammatory mediators such as 
tumor necrosis factor-α of interleukin-1749,252. 
Preliminary data from Garlet group demonstrate 
that both interleukin-9 and interleukin-22 are 
overexpressed in diseased periodontal tissues, 
reinforcing the complexity of cytokine networks 
in the inflamed periodontal environment. Here, 
we simultaneously investigated the expression of 
pro- and anti-inflammatory, T-helper 1, T-helper 
2, T-helper 9, T-helper 17, T-helper 22 and 
T-regulatory cells cytokines/markers, and the 
major osteoclastogenesis regulators RANKL and 
osteoprotegerin, in human chronic periapical 
granulomas and their possible correlations with 
lesions activity pattern147 in order to obtain a more 
complete picture of the immunoregulatory scenario 
in periapical lesions, which ultimately can contribute 
to the development and to the improvement of the 
diagnosis and treatment of these pathologies.
The T helper immunoregulatory network
Despite the reports regarding the expression 
of prototypical T-helper markers in diseased 
periodontal tissues, the related hypothesis 
regarding their role in the pathogenesis of 
periodontal diseases are often conflicting. In fact, 
since the production/expression of such factors is 
usually investigated individually or in small clusters, 
it does not allow the complete immunoregulatory 
scenario determination, where the potential 
synergic or antagonist action of cytokines should 
be considered. When interpreting in vivo data, the 
putative function of cytokines must be estimated 
in the view of a complex milieu, with presence of 
several other cytokines, which can modulate or 
be modulated by them in multiple ways until the 
establishment of an overall outcome. In addition, 
since the presence of specific periodontopathogens 
is able to interfere with cytokine milieu, the in 
vivo scenario with multiple bacterial species 
turns this network even more complex (Figure 
3). Interestingly, the simultaneous presence of 
T-helper 1 and T-helper 2 was previously reported 
in periodontal lesions, but the interferon-g and 
interleukin-4 levels of these cytokines were 
described to be inversely correlated in accordance 
with the mutual inhibitory activity of these T cell 
subsets62. More recently, studies demonstrate that 
periodontal lesions simultaneously express high 
levels of both interleukin-17 and interferon-g, 
suggesting a possible cooperative detrimental 
role for these cytokines46,223. Conversely, in other 
models, T-helper 1 and T-helper 17 mediators seem 
to be independently associated to the progression 
Figure 3- Cytokines and periodontal disease
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of inflammatory bone lesions, suggesting that 
distinct pathways could result in a similar bone 
loss outcome26,236,244. The possible interactions 
among T-helper subsets would also involve 
potentially protective mechanisms, since a 
T-helper 2/T-regulatory cells crosstalk mediated 
by transforming growth factor-β and interleukin-4 
may drive the polarization of T-helper 9 cells103, 
described to mediate immunosuppressive actions 
along interleukin-4 and interleukin-10 producing 
cells229,257.
Oral viruses in pathogenesis of periodontal 
disease
Periodontitis is considered to be a process that 
involves a multifactorial interaction among microbial, 
host and environmental modulating factors84. It is 
accepted that periodontitis is associated with specific 
bacterial species and polymicrobial colonization of 
the teeth surfaces6, however, the amount of bacterial 
plaque per se does not completely explain the 
clinical and pathological features of periodontitis32. 
Periodontal diseases are inflammatory processes 
characterized by dense accumulation of immune 
cells, including polymorphonuclear neutrophils, 
T and B lymphocytes, plasma cells, mast cells, 
monocytes and macrophages25. The T cells play 
an important role in the immune response, 
regulating the polyclonal activation of the B cells 
and plasma cells in the periodontitis-affected sites. 
The interaction between host immune system and 
periodontopathogens is relevant to the pathogenesis 
of periodontitis53.
Our knowledge of viral infections has increased 
significantly in the past couple of decades. 
Herpesviruses may cause illness by mechanisms 
that are direct, indirect or immune-response 
linked, and illnesses range from subclinical or 
mild disease to encephalitis, pneumonia and 
other potentially lethal infections, and even to 
lymphoma, sarcoma and carcinoma. In the oral 
cavity, herpesviruses are involved in acute gingival 
infections, destructive periodontal disease, apical 
periodontitis, ulcerations of mucosa, odontogenic 
cyst, giant cell granuloma, autoimmune disease 
and various types of neoplasm33. Contreras, 
et al.33 (1999) suggested that the presence of 
herpesviruses in the periodontal sites could play a 
role on the pathogenesis of human periodontitis. 
Herpesviruses are ubiquitous and after primary 
infection can persist latently in the host in several 
types of cells, including cells of the immune system. 
The cytomegalovirus (CMV) is the most-studied 
member of the betaherpesviruses in periodontal 
sites33. Recently, the other two betaherpesviruses, 
known as human herpesvirus 6 (HHV-6) and human 
herpesvirus 7 (HHV-7), have been investigated 
because these viruses are frequently detected in 
saliva208,209.
Inflammatory cells harboring herpesviruses 
present at sites of periodontal inflammation could 
contribute to the development and course of 
periodontitis32. Cytomegalovirus can induce direct 
cytopathic effects on fibroblasts, keratinocytes, 
endothelial cells and inflammatory cells, including 
polymorphonuclear leukocytes, T lymphocytes and 
macrophages, and also possibly affect bone cells210.
In periodontitis patients, T cells are activated, 
and specific lymphocyte responses are driven by 
the nature of the initial antigenic stimuli. This 
process is supported by a complex cascade of 
events involving cytokines, chemokines and other 
inflammatory mediators, which could be altered due 
to cytomegalovirus infection209. Proinflammatory 
and anti-inflammatory balances controlled by 
different subsets of lymphocytes are thought to be 
crucial in the pathogenesis of periodontitis53.
The expression of different cellular antigens can 
be dramatically altered in Beta herpesvirus-infected 
tissues, in which the viral infection can induce CD4 
up regulation and CD3 down modulation in the T 
cells. Human herpesvirus 6 can severely affect the 
physiology of secondary lymphoid organs through 
direct infection of T lymphocytes and modulation of 
key membrane receptors and chemokines74.
Local immunomodulatory effects caused by 
herpesviral infection could facilitate bacterial 
proliferation and virulence, or induce the release 
of cytokines and chemokines from inflammatory 
and connective tissue cells214. In addition, viruses 
and bacteria could act in synergy to produce 
pathology210.
Herpesviral infections in the periodontium 
can act as cofactors of periodontal pathogenesis, 
modulating the activity of inflammatory cells. 
The release of different types of cytokines and 
B lymphocyte activation orchestrated by T 
lymphocytes has been shown to be an important 
process in chronic periodontitis. In addition, T-regs 
cells may be involved in local immune response in 
periodontitis25.
In conclusion, a herpesvirus-bacterial pathogen 
model has been proposed, in which viral infections 
facilitate bacterial overgrowth and virulence. 
Moreover, the immunosuppressive effects of certain 
herpesviruses can also perpetuate the inflammatory 
reaction in the connective tissue facilitating 
periodontal destruction. Human viruses could play 
a role in human periodontitis by modulation of 
immune response.
IV- OSTEO-IMMUNOLOGY  IN 
PERIODONTAL DISEASES
Nowadays, it has been clearly demonstrated 
that increases in RANKL mRNA and protein levels 
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in periodontal tissues stimulate the differentiation 
of monocyte-macrophage precursor cells into 
osteoclasts, and the maturation and survival of 
the osteoclast, leading to alveolar bone loss37,54,91, 
108,132,156,244,248. In this context, during inflammatory 
response character ist ic of per iodont it is, 
proinflammatory cytokines associated with 
T-helper 1 and T-helper 17 cell phenotypes, such 
as interleukin-1β, interleukin-6, interleukin-17, 
interferon-γ, and tumor necrosis factor-α, can 
stimulate periodontal osteoblasts to express 
membrane-bound RANKL1,54,72,140,153. In addition to 
osteoblasts, RANKL is expressed by a number of 
other cell types, mainly T-helper 17 lymphocytes108 
(Figure 4).
Skeletal homeostasis depends on a dynamic 
balance between the activities of the bone-
forming osteoblasts (OBLs) and bone-resorbing 
osteoclasts (OCLs)247. This balance is tightly 
controlled by various regulatory systems, such 
as the endocrine system, and is influenced by the 
immune system, an osteoimmunological regulation 
depending on lymphocyte- and macrophage-
derived cytokines188,197,225,251. An unbalance in favor 
of bone-resorbing osteoclasts leads to pathological 
bone resorption, as it has been observed in 
rheumatoid arthritis, osteoporosis, Paget’s disease, 
bone tumors, and periodontitis188,251.
During the 1970’s, the first observation pointing 
towards immune cells influencing the bone-
resorbing osteoclasts activity was made. Indeed, a 
factor (OCL-activating factor or OAF) that stimulated 
bone resorption was detected in the supernatant 
from cultured human peripheral monocytes 
stimulated with phytohemagglutinin96. Purification 
of this activity led to the identification of interleukin-
1β41. Nowadays, numerous cytokines have been 
demonstrated to stimulate bone resorption, 
including tumor necrosis factor-α, interleukin-
1α, interleukin-1β, interleukin-6, interleukin-11, 
interleukin-15, and interleukin-17, whereas others 
such as interleukin-4, interleukin-5, interleukin-10, 
interleukin-13, interleukin-18, and transforming 
growth factor-β1 inhibited bone resorption225,251. 
In this context, functional characterization of 
three novel members of the tumor necrosis factor-
ligand and receptor superfamily, the receptor 
activator of nuclear factor-κB (RANK), its ligand 
(RANK-ligand or RANKL) and the soluble decoy 
receptor of RANKL named osteoprotegerin, have 
contributed significantly to the establishment of 
osteoimmunology, where these molecular mediators 
participate as key modulators of physiological and 
pathological bone resorption224,234,250. RANKL exerts 
its biological effects directly through binding to 
RANK, inducing OCL differentiation, maturation 
and activation124. Osteoprotegerin inhibits the 
osteoclastogenesis and induces osteopetrosis when 
over-expressed in transgenic mice205. RANKL has 
been associated with diverse osteodestructive 
pathologies, including rheumatoid arthritis, bone 
tumors, osteoporosis, Paget’s bone disease, 
osteolytic lesions of the facial skeleton, odontogenic 
lesions and periodontitis28,37,90,96,97,117,132,231,245,246.
The identification of RANKL as the T cell 
cytokine TRANCE (tumor necrosis factor-related 
activation-induced cytokine) allowed envisaging the 
possibility that CD4+ T cells may have the capacity 
to induce OCL differentiation and activation by 
directly acting on OCL precursors and on mature 
OCLs through synthesis of RANKL during osteo-
destructive diseases117,230,260. Furthermore, many 
well-known osteotropic factors, including tumor 
necrosis factor-α, interleukin-1β and interleukin-6, 
exert their osteoclastogenic activity by inducing 
RANL expression on OBLs and CD4+ T cells22. Th2 
Figure 4- Periodontal disease osteoimmunology
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cells inhibit osteoclastogenesis by acting on the 
precursor cells, mainly through interleukin-4 and 
interleukin-10 secretion95,239. In contrast, T-helper 
17 cells stimulated by interleukin-23 promote 
osteoclastogenesis mostly through production 
of interleukin-17 and RANKL196. Furthermore, 
interleukin-17 facilitates local inflammation by 
recruiting and activating immune cells, which leads 
to an abundance of inflammatory cytokines such 
as interleukin-1β and tumor necrosis factor-α that 
enhance the RANKL expression on OBLs and Th17 
cells27,43.
T-helper 17 cells represent a large proportion 
of the inflammatory cells invading the synovial 
tissues during rheumatoid arthritis27. High levels of 
interleukin-17A have been detected in the synovial 
fluid, and interleukin-17-producing cells have been 
detected within the T cell-rich areas in patients with 
rheumatoid arthritis138,264. Furthermore, interleukin-
17A is able to promote cartilage destruction and 
bone erosion in experimental rheumatoid arthritis138. 
Increased levels of interleukin-17 were detected in 
gingival crevicular fluid and in biopsy samples from 
periodontal lesions, both at the mRNA and protein 
levels, in patients with chronic periodontitis, and 
these increased levels have been associated to 
CD4+ T cells223,247. Furthermore, RANKL and RANK 
were synthesized within periodontal lesions in which 
interleukin-17 was produced by activated gingival 
T cells247. Taken together, these data establish that 
T-helper 17 cells represent the osteoclastogenic 
T-helper subset on CD4+ T lymphocytes, inducing 
osteoclastogenesis and bone resorption through 
synthesizing interleukin-17 and RANKL (Figure 5).
Our findings have demonstrated that total 
amount of RANKL detected in gingival crevicular fluid 
of patients undergoing periodontitis progression 
was higher in active periodontal lesions than in 
inactive lesions, proposing this pro-resorptive factor 
as a marker of active alveolar bone resorption 
associated with T-helper cell activity245,246. This 
finding was corroborated by Silva, et al.204 (2008), 
whom performed a longitudinal following of 56 
patients affected by moderate to severe chronic 
periodontitis until determination of progression, 
detecting higher RANKL and interleukin-1β levels, 
and matrix metalloproteinase-13 activity, in active 
sites compared with inactive sites.
When the role of T-helper 17 and T regulatory 
cells phenotypes was analyzed during progressive 
periodontitis, it was established that interleukin-17 
and RANKL were over-regulated, and interleukin-10 
and transforming growth factor-β1 were down-
regulated in active periodontal lesions compared 
with inactive lesions activity45. In fact, the over-
expression of transcription factor orphan nuclear 
receptor C2 (RORC2), the master-switch gene 
controlling the T-helper 17 differentiation, was 
associated with active periodontal lesions during 
progressive periodontitis45.
In the same study, analysis of the associations 
between different genes yielded significant positive 
correlations between RORC2 and RANKL, and 
between RORC2 and interleukin-17. However, 
Foxp3, interleukin-10, transforming growth 
factor-β1, and CTLA-4 did not show a positive 
correlation, speculating that Foxp3+ T-cells that do 
not bear regulatory functions may have a role in 
periodontal progressive destruction, in view of the 
down-regulation of interleukin-10 and transforming 
growth factor-β145.
In response to periodontopathogens that 
have been strongly associated with periodontitis 
progression, for instance P. gingivalis and A. 
actinomycetemcomitans, RANKL expression has 
been reported to increase in CD4+ T lymphocytes 
infiltrating periodontally affected tissues258. 
In this context, on T lymphocytes activated 
with autologous dendritic cells primed with 
different P. gingivalis capsular (K) serotypes and 
A. actinomycetemcomitans O-polysaccharide 
serotypes, at different multiplicity of infections, 
the expression and secretion levels for RANKL 
were determined. The obtained data showed an 
increase in RANKL mRNA expression on T cells 
activated with P. gingivalis K1 or K2 serotypes and 
A. actinomycetemcomitans b serotype, compared 
with the other serotypes, and these levels correlate 
Figure 5- Osteoclastogenesis and bone resorption induction through synthesizing interleukin-17 and RANKL
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with the levels of secreted RANKL present in the 
supernatant of the cell cultures (unpublished 
data). These data suggested that activation of T 
cells with dendritic cells stimulated with either K1 
or K2 serotypes (P. gingivalis) or b serotypes (A. 
actinomycetemcomitans) induced a T-helper 17 
phenotype in CD4+ T cells, and allowed to speculate 
a link between these serotypes with alveolar 
bone destruction and teeth loosening, one of the 
hallmarks of periodontitis.
Diverse studies have analyzed the concentrations 
of RANKL and osteoprotegerin in gingival crevicular 
fluid of periodontitis patients and healthy 
subjects45,204,245-247. In general, they show great 
variation from study to study, but the ratio of 
RANKL/osteoprotegerin has a consistent tendency 
to increase from periodontal health to periodontitis, 
and to decrease following periodontal treatment. 
The increased RANKL/OPG ratio may serve as 
a biomarker that denotes the occurrence of 
periodontitis, but may not necessarily predict on-
going disease activity14.
V -  T H E  R O L E S  O F  M A T R I X 
M E T A L L O P R O T E I N A S E S  I N 
PERIODONTAL TISSUE BREAKDOWN
The interaction between periodontal inflammation 
and persistent bacterial infection up-regulates the 
expression and activity of neutral proteinases, 
particularly of the matrix metalloproteinase 
family, which contributes to the progressive 
breakdown of periodontal supporting tissue216. 
Matrix metalloproteinases represent a family of 
human zinc-dependent endopeptidases that are 
involved in a wide variety of physiological and 
pathological processes, such as skeletal growth 
and remodeling, wound healing, cancer and 
inflammatory diseases. Matrix metalloproteinases 
are able to degrade basement membrane and 
extracellular matrix components, and therefore 
they have been classically viewed as effectors of 
extracellular matrix hydrolysis. However, matrix 
metalloproteinases have also regulatory properties, 
modulating enzyme, chemokine and cytokine 
activities (referred as bioactive substrates) among 
others, as well as releasing bioactive molecules 
from extracellular matrix store through limited 
proteolysis167,197.
Up to now, 24 matrix metalloproteinases have 
been identified in humans that closely share 
protein sequence and domain structure, and 
they are classically grouped according to their 
structural properties and substrate specificity in 
collagenases, gelatinases, stromelysins, matrilysins 
and membrane type matrix metalloproteinases52. 
The basic structure of matrix metalloproteinases 
is composed of an auto-inhibitory prodomain that 
maintains enzymatic latency, the catalytic domain 
and the C-terminal haemopexin-like domain, 
often involved in the recognition and positioning 
of matrix metalloproteinase substrates. Matrix 
metalloproteinase activity is subjected to a complex 
regulation where the main steps involve gene 
expression, proenzyme activation and inhibition by 
endogenous inhibitors, such as tissue inhibitors of 
matrix metalloproteinases (TIMPs)52,197. As a result 
from matrix metalloproteinase regulation, all human 
matrix metalloproteinases are known to exist in 
multiple forms in periodontal diseases, such as 
latent proforms, active forms, fragmented species, 
complexed species and cell-bound forms. Overall, 
the pathophysiological significance of increased 
matrix metalloproteinase expression and/or levels 
in periodontitis will rely ultimately on endogenous 
matrix metalloproteinase activity, resulting from the 
interactions between their inhibitors and activating 
factors. Consequently, matrix metalloproteinase 
activity accounts for the rate of matrix turnover 
or destruction, and the modulation of the immune 
response in a more direct fashion23,214.
Because collagen I is the main component of the 
extracellular matrix of soft and hard periodontal 
tissues, matrix metalloproteinases with collagen-
degrading properties such as collagenases (matrix 
metalloproteinase-1, -8, -13 and -14) and 
gelatinases (matrix metalloproteinases -2 and 
-9) play a pivotal role in the loss of periodontal 
support213. Collagenases are capable to process 
native collagen without unwinding the triple 
helical assembly of the molecule, generating ¾ 
¼ fragments, whereas gelatinases have been 
defined according to their affinity for denatured 
collagen197. Accordingly, collagenolytic matrix 
metalloproteinases have widely been demonstrated 
in inflamed periodontal tissues and in oral fluids by 
different analytic methods216-218.
Matrix metalloproteinase-8 (collagenase-2) 
is produced by a wide range of resident and 
inflammatory cells, but its main source is the 
neutrophils. Matrix metalloproteinase-8 represents 
the major collagenase in gingival tissue and gingival 
crevicular fluid, accounting for about 80% of 
collagenases in gingival crevicular fluid, followed by 
matrix metalloproteinase-13 (~18%), while matrix 
metalloproteinase-1 is seldom detected69. Despite 
matrix metalloproteinase-8 be widely associated 
with periodontal collagen destruction, increasing 
evidence is emerging regarding its role over bioactive 
substrates during periodontal diseases and wound 
healing. Matrix metalloproteinase-13, also known 
as collagenase-3, is expressed in hypertrophic 
chondrocytes and osteoblasts during human fetal 
development. There is little or no expression of 
matrix metalloproteinase-13 in normal tissues, 
showing a very restricted distribution pattern197. 
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Matrix metalloproteinase-13 upregulation has 
been involved in periodontitis progression, 
particularly in bone loss, and its regulatory role 
is currently under research87,89,99. On the other 
hand, matrix metalloproteinase-1, also known as 
collagenase-1, is produced by several periodontal 
resident cell-types and is considered as central 
in the physiological remodeling of extracellular 
matrix and wound healing197,216. Among gelatinases, 
matrix metalloproteinase-9 is the main gelatinase 
in oral fluids139. Matrix metalloproteinase-9 is 
physiologically expressed by a limited variety of 
cell types, mainly immune cells, and is highly 
inducible under periodontal inflammation, whereas 
matrix metalloproteinase-2 is less inducible and has 
primarily a pro-homeostatic role177,201.
It has been postulated that heritable differences 
in the production of cytokines can influence the 
resistance or susceptibility to periodontitis, as well 
as disease outcome62. Matrix metalloproteinases 
can be released and/or activated during periodontal 
inflammation by proinflammatory cytokines, 
like tumor necrosis factor-α, interleukin-1β, 
reactive oxygen species, and proteases derived 
from the subgingival biofilm and the host121. 
Accordingly, higher mRNA expression levels of 
matrix metalloproteinase/TIMP ratios for matrix 
metalloproteinase-1, -2 and -9, as well as RANKL/
osteoprotegerin ratio, have been reported in 
gingival tissue from chronic and aggressive 
periodontitis patients compared with healthy 
gingival62. Furthermore, comparison between 
gingival tissue from aggressive periodontitis and 
chronic periodontitis showed higher expression 
of the regulatory cytokines interleukin-10 and 
interleukin-4, and reduced Th1- type cytokine 
interferon (IF)- γ expression in the later. The authors 
suggested that different cytokine patterns might 
modify the balance of matrix metalloproteinases/
TIMPs and RANKL/osteoprotegerin, resulting in 
more or less severe periodontal support loss.
Similarly, experimentally-induced periodontitis 
in mice models by A. actinomycetencomitans 
infection in strains selected for maximal and 
minimal inflammatory reactions has demonstrated a 
more severe disease phenotype in the former group. 
Inflammatory profile was composed of higher 
interleukin-1β, tumor necrosis factor-α, RANKL/
osteoprotegerin ratio and matrix metalloproteinase/
TIMP ratio, particularly of matrix metalloproteinase-13 
and matrix metalloproteinase-2238. Similarly, 
matrix metalloproteinase-13 mRNA expression 
levels increase concomitantly with the severity 
of inflammation in two different models of 
experimentally-induced periodontitis, ligature 
placement and lipopolysaccharide injections, but 
the later showed more sustained inflammation. 
However, the authors found a total lack of 
correspondence between mRNA transcription and 
matrix metalloproteinase protein levels8, supporting 
that pro-inflammatory mediators up-regulate 
matrix metalloproteinase expression in periodontal 
diseases, but matrix metalloproteinase protein 
levels and specially matrix metalloproteinase 
activity needs further assessment.
S eve ra l  c ommon  s i n g l e  nu c l e o t i d e 
polymorphisms (SNPs) have been identified in 
matrix metalloproteinase genes; however, their 
association with disease susceptibility or phenotype 
is rather controversial. An example is the matrix 
metalloproteinase-1 -1607 1G/2G variant9,10,174,241. 
A more recent analysis in a Brazilian population 
concluded that the 2G allele associated with 
higher matrix metalloproteinase-1 levels only in 
healthy subjects, whereas in periodontitis patients, 
the antigenic challenge overcame the genetic 
predisposition185. Similar controversial findings have 
been reported for the matrix metalloproteinase-9 
T variant at position -1562 in Czech, Turkish, 
Colombian and Brazilian populations76,92,101,138,219. In 
the case of matrix metalloproteinase-13 and matrix 
metalloproteinase-8, fewer studies are available; 
no differences in matrix metalloproteinase-13- 
77 A/G and -11A/12A polymorphic sites have 
been found for periodontitis patients175. However, 
a recent study revealed that even if no single 
matrix metalloproteinase-8 SNP is associated with 
periodontitis, the haplotype T(-799)/C(+17) is 
associated with clinical manifestations of chronic 
periodontitis in a Czech population102.
A vast array of human studies has addressed 
the association between matrix metalloproteinases 
and periodontitis at the protein level, showing 
that matrix metalloproteinase-8 levels parallel the 
severity of periodontal inflammation and disease. 
Elevated matrix metalloproteinase-8 levels in 
gingival crevicular fluid, saliva and oral rinse 
differentiate periodontitis from gingivitis and healthy 
sites142,145. Furthermore, matrix metalloproteinase-8 
levels can differentiate periodontitis subjects with 
strong inflammatory burden from patients with 
lower levels of inflammation in oral rinse and 
gingival crevicular fluid128,182. Noteworthy, risk 
factors for periodontal disease, such as tobacco 
smoking and type 2 diabetes, have shown to 
influence matrix metalloproteinase-8 levels in 
gingival crevicular fluid and saliva from periodontitis 
subjects81,83,142. Tobacco seems to down-regulate 
matrix metalloproteinase-8 levels; however, the 
sites with progressive periodontitis show similar 
matrix metalloproteinase-8 concentrations, 
irrespective of the smoking status140. Conversely, 
type-2 diabetes elevates collagenase levels36, 
nevertheless, periodontal treatment has shown to 
improve clinical parameters and decrease matrix 
metalloproteinase-8 levels to a similar extent as 
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non-diabetics34.
Our research group has shown that increased 
matrix metalloproteinase-8 levels have been 
identified in its catalytically active form in gingival 
crevicular fluid from progressive periodontitis 
subjects. Among matrix metalloproteinase-8 
isotypes, the neutrophil type predominates over 
the mesenchymal type in progressive periodontitis. 
Active forms of polymorphonuclear neutrophils and 
mesenchymal matrix metalloproteinase-8 types 
and their respective activation ratios tended to 
increase in untreated active sites when compared 
to inactive sites, defined by the tolerance method, 
although it was not significant. Conversely, matrix 
metalloproteinase-8 proforms and total matrix 
metalloproteinase-8 tended to decrease in active 
sites86. In line with these findings, we previously 
assessed collagenase and gelatinase activities 
by a functional activity assay, demonstrating 
increased matrix metalloproteinase activity 
in gingival crevicular fluid from periodontitis 
sites >4 mm compared to shallower pockets/
sulci178. Additionally, we found that non-surgical 
conventional periodontal treatment has proved 
to reduce matrix metalloproteinase-8 and 
matrix metalloproteinase-9 levels and activity 
in accordance with the improvement of clinical 
parameters, whereas non-responsive sites associate 
with sustained matrix metalloproteinase-8 high 
concentrations86,178,206,215. In line with these findings, 
other research groups have proved that adjunctive 
low-dose doxycycline (LDD) can also reduce 
collagenase levels182.
Elevated total matrix metalloproteinase-13 
levels, as well as proenzyme (~60 kDa) and its 
active forms (~45-50 kDa), have been reported 
in chronic periodontitis versus healthy sites 
in gingival crevicular fluid in association with 
periodontal clinical parameters99,111,232 and collagen 
loss48,69. Results from our laboratory undergone in 
chronic periodontitis progression addressed by the 
tolerance method have demonstrated that matrix 
metalloproteinase-13 levels were similar among 
active and inactive sites. However, the former 
sites had higher matrix metalloproteinase-13 
activity, as well as higher bone collagen fragment 
carboxy-terminal telopeptide of type I collagen 
(ICTP), and a trend for reduced levels of its inhibitor 
TIMP-187,89. Based on these data, pathologically 
excessive matrix metalloproteinase-13 levels 
might associate with periodontitis development 
or severity, whereas the occurrence of disease 
activity might be better attributed to the unbalance 
between matrix metalloproteinase-13 and its 
inhibitor, resulting in increased enzyme activity. 
The use of matrix metalloproteinase-13 to reflect 
alveolar bone loss, the hallmark of periodontitis 
progression, has been proposed68,111. These findings 
suggest that active sites display higher collagen 
breakdown and bone catabolism in association 
with matrix metalloproteinase-13 activity. In 
summary, excessive matrix metalloproteinase-8, 
matr ix metal loproteinase-13 and matr ix 
metalloproteinase-9 levels and/or activities have 
been associated with collagen breakdown and 
periodontal inflammation.
Although the activation mechanisms of matrix 
metalloproteinases in vivo are still unclear and 
specific for the affected tissue and disease type, 
it is conceivable that they might play a major 
role during periodontal destruction, based on 
preliminary evidence. Non-proteolytic activation 
of pro-matrix metalloproteinase-8 can be directly 
induced by MPO-derived HOCl in vitro, which 
is likely to represent the most direct activating 
mechanism for triggered neutrophils. MPO can 
also inactivate pathogenic microbes by generating 
reactive oxygen species, as well as inactivating 
TIMPs253. Interestingly, we found a significant 
strong positive correlation between MPO, total 
matrix metalloproteinase-8 levels and matrix 
metalloproteinase-8 active forms from neutrophils 
and mesenchymal cells in both active and inactive 
sites from progressive periodontitis subjects89. 
A positive correlation has also been reported 
between MPO, total matrix metalloproteinase-9 and 
active matrix metalloproteinase-9 in periodontitis 
subjects in an analogue manner as for matrix 
metalloproteinase-8, suggesting a common 
activation mechanism144. Conversely, the later 
study did not find any association between MPO and 
matrix metalloproteinase-8, which might eventually 
be explained regarding the different recognition 
properties of anti-matrix metalloproteinase-8 
antibodies. It has been widely demonstrated 
that antibodies applied in the immunoassays 
for the detection of matrix metalloproteinases 
and their regulators affect the measurement 
outcomes77,128,213,214. Additionally, our study showed 
that periodontally treated active sites, where matrix 
metalloproteinase-8 remained at high levels, 
also demonstrated a persistence of MPO/matrix 
metalloproteinase-8 association89. Based on these 
findings, active sites might have persistently high 
matrix metalloproteinase-8 levels and activation via 
the oxidative pathway. These findings might reflect 
the need for further treatment and follow-up.
Besides the importance of a direct collagenolytic 
role of these matrix metalloproteinases in periodontal 
tissue breakdown, evidence of a relevant matrix 
metalloproteinase regulatory role in periodontitis 
is emerging. In vitro studies demonstrate the 
existence of an activation cascade between 
matrix metalloproteinases -14, -13 and matrix 
metalloproteinase-952,114,115. We recently reported 
matrix metalloproteinase-13 to enhance pro-matrix 
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metalloproteinase-9 activation rate, which was 
further prevented by the administration of a matrix 
metalloproteinase-13 specific synthetic inhibitor 
in gingival tissue from periodontitis patients81. 
Higher matrix metalloproteinase-14 levels have 
also been found in gingival tissue from periodontitis 
subjects compared to controls168, and we reported 
soluble forms of matrix metalloproteinase-14 
in periodontitis gingival crevicular fluid86,232 
along with a positive correlation between active 
matrix metalloproteinase-14 and active matrix 
metalloproteinase-1387. These results suggest 
that collagenolytic matrix metalloproteinases -13, 
-9 and -14 can potentiate their activities through 
proteolytic activation during periodontal disease, 
generating amplifying loops.
Several lines of research based on mouse 
models provide increasing evidence of the 
regulatory properties of matrix metalloproteinases. 
Recently, our group reported that P. gingivalis-
induced experimental periodontitis in matrix 
metalloproteinase-8 null mouse displayed a more 
severe disease phenotype and reduced levels of 
mouse lipopolysaccharide-induced CXC chemokine 
(LIX/CXCL5), the most potent polymorphonuclear 
neutrophil chemoattractant in mice than their wild 
type counterparts85,122,123. Furthermore, LIX/CXCL5 
was immunolocalized to the sulcular epithelium, 
at the oral-periodontal interface. From our 
results, it was suggested that physiologic matrix 
metalloproteinase-8 levels would be required for 
periodontal tissue homeostasis, whereas a complete 
lack of matrix metalloproteinase-8 might result in 
a more severe disease phenotype, resulting from 
a reduced protective polymorphonuclear neutrophil 
response. Accordingly, LIX/CXCL5 levels have also 
shown to diminish, as well as polymorphonuclear 
neutrophil impairment has previously been 
demonstrated in other matrix metalloproteinase-8 
null mouse models78,159,233,242. Nevertheless, direct 
evidence from functional studies is needed to 
confirm this proposal. On the other hand, the 
regulatory effect of matrix metalloproteinase-8 
has further been sustained by other authors that 
showed reduced levels of transforming growth 
factor-β1 in matrix metalloproteinase-8-/- mice 
in association with polymorphonuclear neutrophil 
impaired infiltration and wound healing78. In an 
analogous manner to matrix metalloproteinase-8, 
matrix metalloproteinase-9 activity has shown to 
decrease regulate transforming growth factor-β1 
protein levels in breast cancer cells exposed to 
tamoxifen11,160, whereas recent evidence supports 
that matrix metalloproteinase-13 might modify 
soluble protein levels from RANKL/osteoprotegerin 
axis and consequent bone resorptive activity159.
Overall, immunoassays targeting matrix 
metalloproteinase-8, matrix metalloproteinase-9 
and matrix metalloproteinase-13 in oral fluids 
have a huge potential to differentiate healthy, 
gingivitis and periodontitis sites or subjects, and 
treatment response as a complement to classical 
diagnostic methods86,142,143,145,213,214. We have 
recently assessed the gingival crevicular fluid levels 
of matrix metalloproteinase-8 with two different 
chair-side (dentoAnalyzer by dentognostics GmbH 
and matrix metalloproteinase-8 specific chair-
side dip-stick test) and two laboratory methods 
(immunofluorometric assay IFMA, and commercial 
ELISA)213. Both IFMA and dentoAnalyzer devices 
detected matrix metalloproteinase-8 levels with 
similar reliability. It was concluded that repeatedly 
elevated matrix metalloproteinase-8 levels indicate 
the sites at risk of periodontal attachment loss, 
and that testing of matrix metalloproteinase-8 in 
gingival crevicular fluid might provide a valuable 
side-diagnostic tool, particularly to identify patients 
at risk for periodontitis recurrence145,213.
VI- H O S T - P A T H O G E N 
INTERACTIONS IN PROGRESSIVE 
PERIODONTITIS
Characterization of progressive lesions in chronic 
periodontitis patients has been controversial over 
time, and mechanisms involved in protection 
versus destruction of the host´s periodontium 
are still not fully understood. Evidence indicates 
that periodontal disease has dynamic states of 
exacerbation and remission, which can be described 
in terms of patterns of disease progression and 
regression70,71,133,212. Loss of attachment recorded 
by sequential probing assessments is thought 
to reflect the cumulative effect of such repeated 
episodes and represents the most commonly 
used method to diagnose progressive periodontal 
disease181. Nonetheless, a change in probing depth 
may represent a true change in the attachment level 
and in the tissue tone, or a combination of both106. 
Widespread manifestations of active episodes of 
periodontal disease170 may be associated with 
variations in the supracrestal inflammatory cell 
populations, where significantly higher number 
of mast cells, monocytes/macrophages and 
plasma cells are present in active sites when 
compared with inactive sites263. These cells 
involve the active expression of both catabolic 
cytokines and inflammatory mediators, including 
interleukin-1, interleukin-6, tumor necrosis 
factor-α, etc., through the activation of monocytes/
macrophages, lymphocytes, fibroblasts, and other 
cellular elements involved. These cytokines and 
inflammatory mediators are capable of acting alone 
or together to stimulate alveolar bone resorption 
and collagen destruction via tissue-derived matrix 
metalloproteinases, a major pathway for the 
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breakdown of bony and soft connective tissue, 
associated with periodontal activity119,162.
The theoretical manner in which periodontal 
disease progresses has been a subject of debate. 
Before the 1980´s, based on longitudinal studies133, 
it was assumed that a periodontal lesion progressed 
at a relatively constant rate, and that the progress 
was continuous. Estimations of 0.1 mm per year 
of attachment loss have reinforced the concept of 
continuous disease. As a result, it was common 
to report average periodontal disease progression 
rates in which site-specific measurements were 
averaged per patient, and group averages of the 
patients were then calculated. The acceptance of 
the burst theory implied that etiologic factors of 
periodontitis would not be continuously present 
(in quantity or quality sufficient to produce the 
disease), but would be present (in quantity or 
quality sufficient to produce the disease) only prior 
to and during the burst of the disease activity40. 
During progressive periodontitis, an increased 
number of CD4+ lymphocytes are detected in active 
periodontal lesions, compared with either inactive 
lesions or healthy tissues204. However, analysis 
of T lymphocyte populations by flow cytometry 
in progressive periodontitis reveals similar CD4+/
CD8+ ratios between active and inactive periodontal 
lesions204. In this context, it could be speculated 
that particular T-cell phenotypes are associated 
to active periodontal attachment loss. In fact, an 
increased expression of T-bet, the master switch 
gene controlling the Th1 lymphocyte polarization, 
has been detected in active lesions when compared 
with inactive lesions. Furthermore this T-bet over-
expression correlates positively with the increments 
in the expression of interleukin-1β and IFN-γ45,46.
In progressive periodontitis, it has been difficult 
to determine which T cell subset and specific 
cytokine profiles are destructive and which ones 
are associated with disease resolution, since the 
presence of multiple bacteria in the subgingival 
biofilm, including commensal strains, can modify 
or even switch from a T cell-type of response to 
another28,118. Data regarding the T-helper response 
associated to tissue destruction during periodontitis 
remains controversial. Both T-helper 1-type and 
T-helper 2-type immune responses have been 
associated with active periodontitis and stable 
lesions54,141,228. More recently, a Th17-type of 
response has been associated with periodontitis-
induced tissue destruction24,247,255 and T-regulatory 
cells have been suggested to protect tissues against 
periodontitis24.
Our group has recently analyzed the role of 
T-helper 17 and T-regulatory phenotypes during 
the progression of periodontal destruction45. The 
over-expression of transcription factors RORC2 and 
Foxp3, and cytokines interleukin-17 and RANKL 
were associated with active periodontal lesions 
during progressive periodontitis. Interleukin-10 
and transforming growth factor-β1, however, were 
down-regulated in active periodontal lesions. In fact, 
these regulatory cytokines were over-regulated in 
inactive lesions. The analysis of the associations 
between the different genes yielded significant 
positive correlations between RORC2 and RANKL, 
and between RORC2 and interleukin-17; however, 
Foxp3, interleukin-10, transforming growth 
factor-β1, and CTLA-4 did not show a positive 
correlation, speculating that Foxp3+ T-cells do not 
bear regulatory functions and may have a role in 
periodontal progressive destruction, due to the 
down-regulation of interleukin-10 and transforming 
growth factor-β1. Although T-regulatory and 
T-helper 17 cells play different roles during the 
pathogenesis of infections, it has been demonstrated 
that there exist a reciprocal developmental pathway 
for their generation. Naïve T cells exposed to 
transforming growth factor-β up-regulate Foxp3 
and become induced T-regulatory cells; however, 
when cultured with transforming growth factor-β 
and interleukin-6, naïve T cells generate T-helper 
17 cells with pathologic activities19,259. Thus, when 
the immune response is not activated, transforming 
growth factor-β favors the generation of induced 
T-regulatory cells, which suppress inflammation; 
however, when an infection is established, for 
instance during either gingivitis or early events of 
periodontitis, interleukin-6 is synthesized during the 
innate immune response, inhibiting the generation 
of T-regulatory cells and inducing the differentiation 
of proinflammatory and pro-resorptive T-helper 17 
cells in presence of transforming growth factor-β18. 
Hence, T-regulatory and T-helper 17 cells may 
arise from the same precursor cell and selective 
differentiation would depend on the local cytokine 
milieu, which would determine the predominance 
of either T-regulatory cells with suppressor activity 
or T-helper 17 cells with pathologic activities, 
determining the outcome of the disease.
Our findings have demonstrated that total 
amount of RANKL detected in gingival crevicular fluid 
of patients undergoing periodontitis progression 
was significantly higher in active compared with 
inactive periodontal lesions and, thus, this pro-
resorptive factor could be considered as a marker 
of active alveolar bone resorption associated 
with periodontal infection45,245. This finding was 
corroborated when cytokine mRNA analysis was 
performed using quantitative PCR45. In active 
periodontal lesions, RANKL was significantly 
over-expressed (3.4-fold) compared with inactive 
periodontal lesions. Similarly, interleukin-17 (2.8-
fold), interleukin-1β (3.7-fold) and interferon-γ 
(7.8-fold) were also significantly over-expressed 
in active periodontal lesions. RORC2 (~1.5-fold) 
Host response mechanisms in periodontal diseases
2015;23(3):329-55
J Appl Oral Sci. 348
over-expression, however, was not statistically 
significant45. The analysis of correlations between 
RANKL and interleukin-17 with the different Th-
associated transcription factors yielded positive 
correlation with RORC2 (r=0.966 and r=0.915, 
p<0.01, respectively). A positive correlation was 
also detected between RANKL and interleukin-17 
(r=0.963, p<0.01).
One of the main concerns in progressive 
periodontitis is the definition of active periodontal 
lesions, where tissue destruction is taking place. 
An active periodontal lesion has been characterized 
by a prominent infiltration of activated CD4+ 
T cells204, which express bone destruction-
associated cytokines such as interleukin-17 and 
RANKL45,110,223,246,247. Thus, the predominance of 
T-helper 17 over T-regulatory in active periodontal 
lesions would be directly associated to RANKL-
mediated alveolar bone destruction. All these 
cytokines and inflammatory mediators are 
capable of acting alone or in concert, to stimulate 
periodontal breakdown and collagen destruction 
via tissue-derived matrix metalloproteinases, 
characterizing the progression of periodontitis as a 
stage that presents a significantly host immune and 
inflammatory response to the microbial challenge 
that determines the susceptibility to develop 
destructive/progressive periodontitis under the 
influence of multiple behavioral, environmental and 
genetic factors.
Concluding Remarks
A few bacterial species in the subgingival biofilm 
have been associated with diseased periodontal 
tissues and identified as putative pathogens. It 
was concluded that there is strong evidence that 
P. gingivalis, A. actinomycetemcomitans and T. 
forsythia are periodontal pathogens when its 
presence is in sufficient numbers and in susceptible 
hosts. The bacterial composition of plaque remains 
relatively stable despite regular exposure to minor 
environmental perturbations incorporated into a 
new hypothesis: the ecological plaque hypothesis, 
to explain the relationship between the plaque 
microflora and the host in health and disease, and 
to identify new strategies for disease prevention. 
The recent advancements in the periodontal 
research field are consistent with a new model of 
pathogenesis, according to which periodontitis is 
initiated by a synergistic and dysbiotic microbial 
community rather than by a select bacterial 
complex, i.e., polymicrobial synergy and dysbiosis 
model (PSD model).
The innate immune response constitutes a 
homeostatic system, which is the first line of defense, 
and is able to recognize invading microorganisms as 
non-self, triggering immune responses to eliminate 
them. The effectors mechanisms of innate immune 
are improved by adaptive immune involving 
an efficient loop for microbial clearance, where 
triggering of proper innate mechanisms ensure 
an effective adaptive immune response, which 
potentiate these innate effectors functions against 
periodontopathic bacteria. The primary response to 
pathogens in the innate immune system is triggered 
by PRRs that bind PAMPs, found in a broad type 
of organisms. In addition to the innate immunity, 
adaptive immunity cells and characteristic cytokines 
have been described as important players in 
the periodontal disease pathogenesis scenario, 
with a special attention to CD4+ T-cells (T-helper 
cells). Interestingly, T cell-mediated adaptive 
immunity development is highly dependent on 
innate immunity-associated antigen presenting 
cells, which after antigen capture undergo into a 
maturation process and migrate towards the lymph 
nodes, where produce distinct patterns of cytokines 
that will contribute to the subsequent polarization 
and activation of specific T CD4+ lymphocyte.
Skeletal homeostasis depends on a dynamic 
balance between the activities of the OBLs and 
OCLs. This balance is tightly controlled by various 
regulatory systems, such as the endocrine system, 
and is influenced by the immune system, an 
osteoimmunological regulation depending on 
lymphocyte- and macrophage-derived cytokines. 
An unbalance in favor of bone-resorbing osteoclasts 
leads to pathological bone resorption as it has been 
observed in rheumatoid arthritis, osteoporosis, 
Paget’s disease, bone tumors, and periodontitis. 
Diverse studies have analyzed the concentrations 
of RANKL and osteoprotegerin in gingival crevicular 
fluid of periodontitis patients and healthy subjects. 
In general, they show great variation from study to 
study, but the ratio of RANKL/osteoprotegerin has 
a consistent tendency to increase from periodontal 
health to periodontitis and to decrease following 
periodontal treatment.
Matrix metalloproteinases can be released and/
or activated during periodontal inflammation by 
proinflammatory cytokines, like tumor necrosis 
factor-α, interleukin-1β, reactive oxygen species, 
and proteases derived from the subgingival 
biofilm and the host118. Accordingly, higher mRNA 
expression levels of matrix metalloproteinase/
TIMP ratios for matrix metalloproteinase-1, -2 and 
-9, as well as RANKL/osteoprotegerin ratio, have 
been reported in gingival tissue from chronic and 
aggressive periodontitis patients compared with 
healthy gingival tissue.
Characterization of progressive lesions in chronic 
periodontitis patients has been controversial 
over time and mechanisms involved in protection 
versus destruction of the host´s periodontium 
are still not fully understood. Evidence indicates 
that periodontal disease has dynamic states of 
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exacerbation and remission, which can be described 
in terms of patterns of disease progression and 
regression. Loss of attachment recorded by 
sequential probing assessments is thought to 
reflect the cumulative effect of such repeated 
episodes, and represents the most commonly 
used method to diagnose progressive periodontal 
disease. Nonetheless, a change in probing depth 
may represent a true change in the attachment 
level, a change in tissue tone, or a combination of 
both. Widespread manifestations of active episodes 
of periodontal disease may be associated with 
variations in the supracrestal inflammatory cell 
populations, where significantly higher number of 
mast cells, monocytes/macrophages and plasma 
cells are present in active sites when compared 
with inactive sites.
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